Rationale:Accumulating data support a therapeutic role for mesenchymal stem cell (MSC) therapy; however, there is no consensus on the optimal route of delivery. Objective:We tested the hypothesis t...
CITATION STYLE
Kanelidis, A. J., Premer, C., Lopez, J., Balkan, W., & Hare, J. M. (2017). Route of Delivery Modulates the Efficacy of Mesenchymal Stem Cell Therapy for Myocardial Infarction. Circulation Research, 120(7), 1139–1150. https://doi.org/10.1161/circresaha.116.309819
Mendeley helps you to discover research relevant for your work.